Rapid Microbiology Testing Market

Rapid Microbiology Testing Market by Method (Growth, Viability), Product (Automated Microbial Identification & AST System, PCR, Reagent), Application (Clinical Diagnosis, Environmental), End User (Labs, Hospitals, Industry) - Global Forecast to 2023

Report Code: MD 6602 Sep, 2018, by marketsandmarkets.com

[188 Pages Report] The global rapid microbiology testing market is expected to 5.09 billion by 2023 from USD 3.45 billion in 2018, growing at a CAGR of 8.1%.

Rapid Microbiology Testing Market

By product, the instruments segment is expected account for the largest share

Based on product, the global rapid microbiology testing market is segmented into instruments, reagents & kits, and consumables. In 2018, the instruments segment is expected to account for the largest share of the market owing to factors such as the significant adoption of modern laboratory instruments in the research and academic sectors (coupled with growing industry-academia collaborations for genomic research) and the ongoing trend of laboratory automation among clinical laboratories.

By method, the growth-based rapid microbiology testing segment is expected account for the largest share

Based on method, the global rapid microbiology testing market is divided into five segments-growth-based, viability-based, cellular component-based, nucleic acid-based, and other testing methods. The growth-based rapid microbiology testing segment is expected to account for the largest share of the market in 2018. The large share of this segment can be attributed to factors such as the ease of processing (this method uses conventional liquid or agar media), the limited requirement of skilled professionals, and supportive government regulations.

By application, the clinical disease diagnosis application segment is expected account for the largest share

On the basis of application, the rapid microbiology testing market is segmented into clinical disease diagnosis, food & beverage testing, pharmaceutical & biological drug testing, cosmetics and personal care products testing, environmental applications, research applications, and other applications. The clinical disease diagnosis application segment is expected to dominate the rapid microbiology testing market during the forecast period. This can primarily be attributed to the increasing use of rapid microbiology testing for the diagnosis of infectious diseases in humans; rising emphasis on effective and early disease diagnosis across major markets; and the introduction of advanced, accurate, and rapid methods for faster clinical diagnosis.

By end user, the diagnostic laboratories & hospitals segment is expected account for the largest share

The rapid microbiology testing market, by end user, is segmented into diagnostic laboratories & hospitals, food & beverage companies, pharmaceutical companies, CROs, and other end users. In 2018, the diagnostic laboratories & hospitals segment is expected to account for the largest share of the rapid microbiology testing market. Some of the key factors driving the growth of this segment are the increasing prevalence of infectious diseases, improving healthcare expenditure, and technological advancements in rapid microbial testing.

North America is expected to account for the largest share of the rapid microbiology testing market during the forecast period

The report covers the rapid microbiology testing market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global rapid microbiology testing market in 2018. Technological advancements in the field of rapid microbial testing, the rising incidence of infectious diseases, and growing food safety concerns are driving the growth of the rapid microbiology testing market in North America. Additionally, easy accessibility and high adoption of advanced diagnostic technologies owing to the significant per capita annual healthcare expenditure by the US and Canadian governments are increasing the adoption of rapid microbiology testing in this region. The Asia Pacific region is expected to grow at the highest CAGR due to the increasing healthcare expenditure and growing initiatives to promote the use of advanced rapid microbiology testing technologies in Asia Pacific countries.

Rapid Microbiology Testing Market

Rapid microbiology Testing Market, By Region

Rapid Microbiology Testing Market

Market Dynamics

Growth in the rapid microbiology testing market can be attributed to factors such as the rising prevalence of infectious diseases; ongoing technological advancements; increasing food safety concerns; increased funding, research grants, and public-private investments; and increasing awareness about rapid microbiology testing.

Driver- Technological advancements

Over the years, there has been a gradual shift from conventional microbiology testing toward rapid testing methods. This shift has been driven by the introduction of newer and faster technologies to avert the need for the biological amplification of bacteria for detection. Rapid advancements in the field of microbial testing help to overcome limitations such as long procedural times and long exposure to pathogenic strains with conventional testing methods. Continuous technological advancements in microbiology testing, in terms of efficacy, efficiency, accuracy, faster results, and improved functionality, are generating increased interest among clinical laboratories, hospitals, academic institutes, research laboratories, and pharmaceutical and biotechnology companies.

These tests provide a cost-effective alternative for microbial identification by reducing the per procedure consumable cost. Clinical diagnostics, food and beverage testing, and environmental applications use rapid technologies in microbial identification to identify microbes from different samples. With recent advances in genomics and proteomics, microbial identification and quantification methodologies have evolved rapidly. Several emerging molecular diagnostic techniques are increasingly being used for early detection as they eliminate the complex needs of detecting the whole organism by amplifying cellular components, like nucleic acid, or using signal amplification to enhance detection capability.

Owing to changing end-user preferences, many prominent product manufacturers are highly focused on the development and commercialization of innovative and technologically advanced molecular diagnostic products for rapid microbiology testing. Recent developments in this regard include:

  • In 2016, bioM้rieux (France) enhanced its VITEK MS system’s performance by improving and updating its database and reagent kits to include the identification of 297 new species.
  • In 2016, BD (US) introduced the Phoenix M50 ID/AST system for susceptibility testing.
  • In 2016, Bruker (US) launched an updated version of its MALDI Biotyper system to provide high-speed and accurate identification and taxonomical classification of bacteria, yeasts, and fungi.
  • In 2015, Danaher Corporation (US) introduced the MicroScan WalkAway plus, a customizable solution for microbial identification.
  • In 2015, Rapid Micro Biosystems (US) expanded its existing Growth Direct technology platform with the launch of the Growth Direct MultiTest System.
  • In 2015, Neogen (US) launched AccuPoint Advanced ATP sanitation monitoring system, with improved sampler chemistry and fast results (in less than 20 seconds).

Restraint- Unfavorable reimbursement policies

Clinical microbiology testing procedures are not adequately reimbursed across various countries, especially India, China, and other emerging countries in the Middle East and Africa, which have a high target patient population base. This affects the adoption of premium-priced clinical microbiology products, thereby negatively affecting their market growth.

In the US, Medicare does not provide any additional reimbursement for the treatment of HAIs, which limits the use of microbial testing for HAIs. Healthcare service coding includes CPT codes, maintained by the American Medical Association (AMA), which are used in combination with the International Classification of Diseases (ICD) codes for patient diagnosis and reimbursements. Updating existing CPT/ICD codes or allotting a new code is a complex and lengthy process that takes up to five years of data tracking. Additionally, even after the notification of a new code, insurance coverage for a new test procedure may vary by insurer or payment mechanism. 

The lack of national standardization for reimbursements results in significant variation at the regional level. The adoption of microbial tests in the US is further restricted due to limited coverage of operational costs for these test procedures, restricted research use only (RUO) diagnostic products, and the slow inclusion of newly developed microbial test procedures in CPT codes for medical reimbursements. These unfavorable reimbursement policies may affect the adoption of products, which will ultimately restrict market growth to a certain extent.

Scope of the Report

Report Metric

Details

Market Size Available for Years

2016–2023

Base Year Considered

2017

Forecast Period

2018–2023

Forecast Units

Value (USD)

Segments Covered

Method, Product,  Application, End User, and Region

Geographies Covered

North America (US & Canada), Europe (Germany, France, UK, Spain, Italy and RoE), APAC (China, Japan, India, South Korea, Australia and RoAPAC), and Latin America, and the Middle East & Africa

Companies Covered

bioM้rieux (France), BD (US), Danaher (US), Thermo Fisher (US), Bio-Rad (US), Hi-Media (India), MERLIN (Germany), Liofilchem (Italy), Accelerate (US), Alifax (Italy), Creative Diagnostics (US), Merck Group(Germany), Synbiosis (UK), Bioanalyse (Turkey), and Zhuhai DL Biotech (China). Major 15 players covered.

This report categorizes the global rapid microbiology testing market into the following segments and subsegments:

Global Rapid Microbiology Testing Market, by Product

  • Instruments
    • Automated ID/AST Systems
    • Mass Spectrometers
    • PCR Systems
    • Cytometers
    • Active Air Samplers
    • Bioluminescence- and Fluorescence-based Detection Systems
    • Other Instruments (Raman spectroscopy systems, microfluidics and microarray systems, and biochemical and impedance systems)
  • Reagents & Kits
    • Sterility Testing Reagents & Kits
    • Other Reagents & Kits (enzyme-linked immunosorbent assays (ELISA) and enzyme immunoassays (EIA), lateral flow assays, and PCR kits)           
  • Consumables

Global Rapid Microbiology Testing Market, by Method

  • Growth-based
  • Viability-based
  • Cellular Component-based
  • Nucleic Acid-based
  • Other Rapid Microbiology Testing Methods (micro-electrical-mechanical systems (MEMS) and optical spectroscopy)

Global Rapid Microbiology Testing Market, by Application

  • Clinical Disease Diagnosis
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Cosmetics & Personal Care Products Testing
  • Environmental Testing
  • Research Applications
  • Other Applications (chemicals, paints, and biofuels)

Global Rapid Microbiology Testing Market, by End User

  • Diagnostic Laboratories & Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Food & Beverage Companies
  • Contract Research Organizations
  • Other End Users (environmental study agencies, NGOs, academic institutes, cosmetics and personal care testing industry, and research laboratories)

Global Rapid Microbiology Testing Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UKs
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

Key Market Players:

Some of the prominent players in the rapid microbiology testing market include bioM้rieux SA (France). Abbott Laboratories Inc. (US), Danaher Corporation (US), and Becton, Dickinson and Company (US). Other players in this market include Bruker Corporation (US), Charles River Laboratories International, Inc. (US), Don Whitley Scientific Limited (UK), Merck KGaA (Germany), Neogen (US), Quidel Corporation (US), Rapid Micro Biosystems, Inc. (US), Sartorius Group (Germany), Thermo Fisher Scientific (US), TSI Inc. (US), and Vivione Biosciences, LLC (US).

bioM้rieux is one of the leading players in the rapid microbiology testing market. The company has a robust product portfolio and a strong geographical presence in more than 150 countries across the world. The company has a comprehensive range of solutions for rapid microbial identification, resistance detection, and diagnosis of bacterial infection. In 2017, the company focused extensively on research and development efforts to accelerate the growth, with ~13.3% of its sales invested in R&D. This heavy investment in R&D is driving the launch of new and technologically improved products by the company. For instance, in July 2016, the company enhanced its VITEK MS system’s performance by improving and updating its database and reagent kits to include the identification of 297 new species. Similarly, during 2014–2018, the company launched several products in the clinical testing space, such as VITEK MS, FilmArray 2.0, FilmArray Respiratory PanelBacT/ALERT VIRTUO system, and FilmArray Gastrointestinal (GI) Panel. This helped the company to strengthen its position and expand its revenue in the rapid microbiology testing market.

Recent Developments:

  • In 2018, Becton, Dickinson and Company (US), received CE Mark for its next-generation molecular screening test for antibiotic-resistant carbapenemase-producing organisms (CPOs) to be used on BD MAX system
  • In 2017, Abbott completed the acquisition of Alere, to expand its product portfolio and strengthen its market position in the rapid microbiology testing market
  • In 2017, Merck KGaA (Germany), signed agreement with OpGen, Inc. (US), to develop rapid diagnostics and information technology products to help combat the threat of antimicrobial resistance
  • In 2016, bioM้rieux (US), acquired Astute Medical Inc. to expand its immunoassays product portfolio.

Critical questions the report answers:

  • What are the growth opportunities related to the adoption of rapid microbiology testing market across major regions in the future?
  • Emerging countries have immense opportunities for the growth and adoption of rapid microbiology testing. Will this scenario continue in the next five years?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the new trends and advancements in the rapid microbiology testing market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders

2 Research Methodology (Page No. - 20)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
           2.1.3 Market Size Estimation
           2.1.4 Product-Based Market Estimation
           2.1.5 Volume-Based Market Estimation
           2.1.6 Primary Research Validation
    2.2 Market Breakdown and Data Triangulation
    2.3 Research Limitations and Assumptions
           2.3.1 Limitations
           2.3.2 Assumptions

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 37)
    4.1 Rapid Microbiology Testing Market  Overview
    4.2 Regional Analysis: Rapid Microbiology Testing Market, y Product
    4.3 Rapid Microbiology Testing Reagents Market, By Type
    4.4 Asia Pacific: Rapid Microbiology Testing Market, By Method, 2018
    4.5 Rapid Microbiology Testing Market, By Application
    4.6 Regional Analysis: Rapid Microbiology Testing Market By End User
    4.7 Rapid Microbiology Testing Market,  By Country

5 Market Overview (Page No. - 43)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rising Incidence of Infectious Diseases
                    5.2.1.2 Technological Advancements
                    5.2.1.3 Increasing Food Safety Concerns
                    5.2.1.4 Funding, Research Grants, and Public-Private Investments
           5.2.2 Restraints
                    5.2.2.1 Unfavorable Reimbursement Policies
           5.2.3 Opportunities
                    5.2.3.1 Government Initiatives for the Detection of Antimicrobial Resistance
                    5.2.3.2 Emerging Countries
                    5.2.3.3 Bioterrorism Surveillance
           5.2.4 Challenges
                    5.2.4.1 High Cost of Rapid Microbiology Testing Instruments
           5.2.5 Burning Issues
                    5.2.5.1 Bundled Sales By Market Giants
                    5.2.5.2 Stringent Policies and Expected Regulatory Changes

6 Rapid Microbiology Testing Market, By Method (Page No. - 53)
    6.1 Introduction
    6.2 Growth-Based Rapid Microbiology Testing
    6.3 Cellular Component-Based Rapid Microbiology Testing
    6.4 Nucleic Acid-Based Rapid Microbiology Testing
    6.5 Viability-Based Rapid Microbiology Testing
    6.6 Other Rapid Microbiology Testing Methods

7 Rapid Microbiology Testing Market, By Product (Page No. - 62)
    7.1 Introduction
    7.2 Instruments
           7.2.1 Automated Microbial Identification and Antimicrobial Susceptibility Testing Systems
           7.2.2 Mass Spectrometers
           7.2.3 Pcr Systems
           7.2.4 Bioluminescence- and Fluorescence-Based Detection Systems
           7.2.5 Cytometers
           7.2.6 Active Air Samplers
           7.2.7 Other Instruments
    7.3 Reagents & Kits
           7.3.1 Sterility Testing Reagents & Kits
           7.3.2 Other Reagents & Kits
    7.4 Consumables

8 Rapid Microbiology Testing Market,By Application (Page No. - 76)
    8.1 Introduction
    8.2 Clinical Disease Diagnosis
    8.3 Food & Beverage Testing
    8.4 Pharmaceutical & Biological Drug Testing
    8.5 Environmental Testing
    8.6 Cosmetics & Personal Care Products Testing
    8.7 Research Applications
    8.8 Other Applications

9 Rapid Microbiology Testing Market, By End User (Page No. - 87)
    9.1 Introduction
    9.2 Diagnostic Laboratories & Hospitals
    9.3 Food & Beverage Companies
    9.4 Pharmaceutical & Biotechnology Companies
    9.5 Contract Research Organizations
    9.6 Other End Users

10 Rapid Microbiology Testing Market,  By Region (Page No. - 95)
     10.1 Introduction
     10.2 North America
             10.2.1 US
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 UK
             10.3.4 Rest of Europe (RoE)
     10.4 Asia Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 South Korea 
             10.4.5 Australia 
             10.4.6 Rest Of Asia Pacific (RoAPAC)
     10.5 Latin America 
             10.5.1 Brazil 
             10.5.2 Mexico 
             10.5.3 Rolatam 
     10.6 Middle East & Africa

11 Competitive Landscape (Page No. - 139)
     11.1 Introduction
     11.2 Market Share Analysis
     11.3 Competitive Scenario
             11.3.1 Product Launches, Approvals, and Enhancements
             11.3.2 Acquisitions
             11.3.3 Collaborations and Agreements
             11.3.4 Expansions
     11.4 Vendor Dive Overview 
     11.5 Vendor Inclusion Criteria 
     11.6 Vendor Dive 
             11.6.1 Visionary Leaders 
             11.6.2 Innovators 
             11.6.3 Dynamic Differentiators 

12 Company Profiles (Page No. - 143)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)* 
     12.1 Abbott Laboratories
             12.1.1 Business Overview
             12.1.2 Products Offered
             12.1.3 Recent Developments
             12.1.4 MnM View
     12.2 Becton, Dickinson And Company
             12.2.1 Business Overview
             12.2.2 Products Offered
             12.2.3 Recent Developments
             12.2.4 MnM View
     12.3 Biom้rieux
             12.3.1 Business Overview
             12.3.2 Products Offered
             12.3.3 Recent Developments
             12.3.4 MnM View
     12.4 Bruker Corporation
             12.4.1 Business Overview
             12.4.2 Products Offered
             12.4.3 Recent Developments
             12.4.4 MnM View
     12.5 Charles River Laboratories International, Inc.
             12.5.1 Business Overview
             12.5.2 Products Offered
             12.5.3 Recent Developments
             12.5.4 MnM View
     12.6 Danaher Corporation
             12.6.1 Business Overview
             12.6.2 Products Offered
             12.6.3 Recent Developments
             12.6.4 MnM View
     12.7 Don Whitley Scientific Limited
             12.7.1 Business Overview
             12.7.2 Products Offered
             12.7.3 Recent Developments
             12.7.4 MnM View
             12.8 Merck KGaA
             12.8.1 Business Overview
             12.8.2 Products Offered
             12.8.3 Recent Developments
             12.8.4 MnM View
     12.9 Neogen Corporation
             12.9.1 Business Overview
             12.9.2 Products Offered
             12.9.3 Recent Developments
             12.9.4 MnM View
     12.1 Quidel Corporation
             12.10.1 Business Overview
             12.10.2 Products Offered
             12.10.3 Recent Developments
             12.10.4 MnM View
     12.11 Rapid Micro Biosystems, Inc.
             12.11.1 Business Overview
             12.11.2 Products Offered
             12.11.3 Recent Developments
             12.11.4 MnM View
     12.12 Sartorius Group
             12.12.1 Business Overview
             12.12.2 Products Offered
             12.12.3 Recent Developments
             12.12.4 MnM View
     12.13 Thermo Fisher Scientific
             12.13.1 Business Overview
             12.13.2 Products Offered
             12.13.3 Recent Developments
             12.13.4 MnM View
     12.14 Tsi, Inc.
             12.14.1 Business Overview
             12.14.2 Products Offered
             12.14.3 Recent Developments
             12.14.4 MnM View
     12.15 Vivione Biosciences, LLC
             12.15.1 Business Overview
             12.15.2 Products Offered
             12.15.3 Recent Developments
             12.15.4 MnM View
     12.16 Other Comapnies
             12.16.1 Business Overview
             12.16.2 Products Offered
*Details On Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies. 

13 Appendix (Page No. - 181)
     13.1 Discussion Guide
     13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.3 Available Customizations
     13.4 Related Reports
     13.5 Author Details


List of Tables (90 Tables)

Table 1 Market, By Method, 2016–2023 (USD Million)
Table 2 Types of Technologies Used in Various Rapid Microbiology Testing Methods
Table 3 Growth-Based Market, By Region, 2016–2023 (USD Million)
Table 4 Cellular Component-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 5 Nucleic Acid-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 6 Viability-Based Rapid Microbiology Testing Market, By Region, 2016–2023 (USD Million)
Table 7 Other Rapid Microbiology Testing Methods Market, By Region, 2016–2023 (USD Million)
Table 8 Market, By Product, 2016–2023 (USD Million)
Table 9 Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 10 Rapid Microbiology Testing Instruments Market, By Region, 2016–2023 (USD Million)
Table 11 Market for Automated Microbial Id/Ast Systems, By Region, 2016–2023 (USD Million)
Table 12 Market for Mass Spectrometers, By Region, 2016–2023 (USD Million)
Table 13 Market for Pcr Systems, By Region, 2016–2023 (USD Million)
Table 14 Market for Bioluminescence- and Fluorescence-Based Detection Systems, By Region, 2016–2023 (USD Million)
Table 15 Market for Cytometers, By Region, 2016–2023 (USD Million)
Table 16 Market for Active Air Samplers, By Region, 2016–2023 (USD Million)
Table 17 Market for Other Instruments, By Region, 2016–2023 (USD Million)
Table 18 Rapid Microbiology Testing Reagents & Kits Market, By Type, 2016–2023 (USD Million)
Table 19 Rapid Microbiology Testing Reagents & Kits Market, By Region, 2016–2023 (USD Million)
Table 20 Market for Sterility Testing Reagents & Kits, By Region, 2016–2023 (USD Million)
Table 21 Market for Other Reagents & Kits, By Region, 2016–2023 (USD Million)
Table 22 Rapid Microbiology Testing Consumables Market, By Region, 2016–2023 (USD Million)
Table 23 Market, By Application, 2016–2023 (USD Million)
Table 24 Market for Clinical Disease Diagnosis, By Region, 2016–2023 (USD Million)
Table 25 Market for Food & Beverage Testing, By Region, 2016–2023 (USD Million)
Table 26 Market for Pharmaceutical & Biological Drug Testing, By Region, 2016–2023 (USD Million)
Table 27 Market for Environmental Testing, By Region, 2016–2023 (USD Million)
Table 28 Market for Cosmetics & Personal Care Products Testing, By Region, 2016–2023 (USD Million)
Table 29 Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 30 Market for Other Applications, By Region, 2016–2023 (USD Million)
Table 31 Market, By End User, 2016–2023 (USD Million)
Table 32 Market for Diagnostic Laboratories & Hospitals, By Region, 2016–2023 (USD Million)
Table 33 Rapid Microbiology Testing Market for Food & Beverage Companies, By Region, 2016–2023 (USD Million)
Table 34 Market for Pharmaceutical & Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 35 Market for Contract Research Organizations, By Region, 2016–2023 (USD Million)
Table 36 Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 37 Market, By Region, 2016–2023 (USD Million)
Table 38 North America: Market, By Country, 2016–2023 (USD Million)
Table 39 North America: Market, By Method, 2016–2023 (USD Million)
Table 40 North America: Market, By Product, 2016–2023 (USD Million)
Table 41 North America: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 42 North America: Market, By Application, 2016–2023 (USD Million)
Table 43 North America: Market, By End User, 2016–2023 (USD Million)
Table 44 US: Market, By Method, 2016–2023 (USD Million)
Table 45 US: Market, By Product, 2016–2023 (USD Million)
Table 46 US: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 47 Canada: Market, By Method, 2016–2023 (USD Million)
Table 48 Canada: Market, By Product, 2016–2023 (USD Million)
Table 49 Canada: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 50 Europe: Rapid Microbiology Testing Market, By Country, 2016–2023 (USD Million)
Table 51 Europe: Market, By Method, 2016–2023 (USD Million)
Table 52 Europe: Market, By Product, 2016–2023 (USD Million)
Table 53 Europe: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 54 Europe: Market, By Application, 2016–2023 (USD Million)
Table 55 Europe: Market, By End User, 2016–2023 (USD Million)
Table 56 Germany: Market, By Method, 2016–2023 (USD Million)
Table 57 Germany: Market, By Product, 2016–2023 (USD Million)
Table 58 Germany: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 59 France: Market, By Method, 2016–2023 (USD Million)
Table 60 France: Market, By Product, 2016–2023 (USD Million)
Table 61 France: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 62 UK: Market, By Method, 2016–2023 (USD Million)
Table 63 UK: Market, By Product, 2016–2023 (USD Million)
Table 64 UK: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 65 RoE: Market, By Method, 2016–2023 (USD Million)
Table 66 RoE: Market, By Product, 2016–2023 (USD Million)
Table 67 RoE: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 68 Asia Pacific: Rapid Microbiology Testing Market, By Country, 2016–2023 (USD Million)
Table 69 Asia Pacific: Market, By Method, 2016–2023 (USD Million)
Table 70 Asia Pacific: Market, By Product, 2016–2023 (USD Million)
Table 71 Asia Pacific: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 72 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 73 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 74 Japan: Market, By Method, 2016–2023 (USD Million)
Table 75 Japan: Market, By Product, 2016–2023 (USD Million)
Table 76 Japan: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 77 China: Market, By Method, 2016–2023 (USD Million)
Table 78 China: Market, By Product, 2016–2023 (USD Million)
Table 79 China: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 80 India: Rapid Microbiology Testing Market, By Method, 2016–2023 (USD Million)
Table 81 India: Market, By Product, 2016–2023 (USD Million)
Table 82 India: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 83 RoAPAC: Market, By Method, 2016–2023 (USD Million)
Table 84 RoAPAC: Market, By Product, 2016–2023 (USD Million)
Table 85 RoAPAC: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 86 RoW: Market, By Method, 2016–2023 (USD Million)
Table 87 RoW: Market, By Product, 2016–2023 (USD Million)
Table 88 RoW: Rapid Microbiology Testing Instruments Market, By Type, 2016–2023 (USD Million)
Table 89 RoW: Market, By Application, 2016–2023 (USD Million)
Table 90 RoW: Market, By End User, 2016–2023 (USD Million)


List of Figures (42 Figures)

Figure 1 Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Bottom-Up Approach Market Size Estimation:  Market
Figure 4 Top-Down Approach Market Size Estimation: Market
Figure 5 Data Triangulation Methodology
Figure 6 Market, By Product, 2018 vs 2023
Figure 7 Rapid Microbiology Testing Instruments Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Market, By Method, 2018 (USD Million)
Figure 9 Market, By Application, 2018 vs 2023
Figure 10 Market, By End User, 2018 vs 2023 (USD Million)
Figure 11 Market, By Region
Figure 12 Incidence of Infectious Diseases, the Key Factor Driving the Growth of the Market
Figure 13 Reagents & Kits Segment to Witness High Growth in the Asia Pacific Market During the Forecast Period
Figure 14 Sterility Testing Reagents & Kits Will Grow at A Faster Rate in the Market in 2018
Figure 15 Growth-Based Segment Will Dominate the Asia Pacific Rapid Microbiology Testing Method Market During in 2018
Figure 16 Clinical Disease Diagnostics Segment to Hold Largest Share of the Market in 2018
Figure 17 North America to Dominate the End-User Market in 2018
Figure 18 China to Witness Highest Growth During the Forecast Period (2018 to 2023)
Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 Deaths Attributable to Antimicrobial Resistance Every Year By 2050
Figure 21 Percentage Change in Annual Healthcare Expenditure: Developed vs Developing Countries (2005–2015)
Figure 22 Growth-Based Rapid Microbiology Testing Segment to Dominate the Market During the Forecast Period
Figure 23 Instruments Segment to Dominate the Rapid Microbiology Testing Products Market
Figure 24 Clinical Disease Diagnosis Applications to Dominate the Market During the Forecast Period
Figure 25 Diagnostic Laboratories & Hospitals are Estimated to Form the Largest End-User Segment in the Market
Figure 26 North America: Rapid Microbiology Testing Market Snapshot
Figure 27 Europe: Market Snapshot
Figure 28 Asia Pacific: Market Snapshot
Figure 29 RoW: Market Snapshot
Figure 30 Key Developments By Leading Market Players in the Market, 2015–2018
Figure 31 Market Share, By Key Player, 2017
Figure 32 Abbott Laboratories: Company Snapshot
Figure 33 Becton, Dickinson and Company: Company Snapshot
Figure 34 Biom้rieux: Company Snapshot
Figure 35 Bruker Corporation: Company Snapshot
Figure 36 Charles River Laboratories International, Inc.: Company Snapshot
Figure 37 Danaher Corporation: Company Snapshot
Figure 38 Merck KGaA: Company Snapshot
Figure 39 Neogen Corporation: Company Snapshot
Figure 40 Quidel Corporation: Company Snapshot
Figure 41 Sartorius Group: Company Snapshot
Figure 42 Thermo Fisher Scientific: Company Snapshot


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
MD 6602
Published ON
Sep, 2018
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Rapid Microbiology Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home